Document:

EX-10.17

 Exhibit 10.17 
 Durata Therapeutics, Inc. 
 Director Compensation and Reimbursement
Policy 
 This Director Compensation and Reimbursement Policy of Durata Therapeutics, Inc. (the
“Corporation”) provides for compensation of each member of the Board of Directors (the “Board”) of the Corporation who is not an employee of the Corporation or any subsidiary of the Corporation and who is not
serving as a representative of an entity that has invested in the Corporation (an “Outside Director”). This Director Compensation and Reimbursement Policy also provides for reimbursement of expenses for all members of the Board.

 Annual Cash Retainers 
 Each Outside Director is entitled to receive an annual cash retainer of $35,000 for service as a director. Each Outside Director who serves as Chairman of the Board also is entitled to receive an
additional annual cash retainer of $15,000. Each Outside Director also is entitled to receive the following additional annual cash retainer for service as the chair or other member of the Board committees set forth below. 

 

									
	 	  	Annual Retainer for Service on
Board Committees	 
	 Committee
	  	Chair	 	  	Other Members	 
	 Audit Committee
	  	$	15,000	  	  	$	7,500	  
	 Organization and Compensation Committee
	  	$	10,000	  	  	$	5,000	  
	 Nominating and Corporate Governance Committee
	  	$	5,000	  	  	$	2,500	  

 Annual cash retainers for service as an Outside Director and as the chair or other member of a Board committee shall be
payable in arrears in four equal quarterly installments on the last day of each quarter; provided that the amount of such payment shall be prorated for any portion of such quarter that the director was not serving on the Board or the applicable
committee. 
 Equity Compensation 
 After the effective date of the Corporation’s 2012 Stock Incentive Plan, as it may be amended from time to time (the “Plan”), the Corporation shall grant to each Outside Director, on the
date of the annual meeting of stockholders of the Corporation, (i) a nonstatutory stock option (an “Annual Option”) to purchase such number of shares of Common Stock having a value, as of such date, that is equal to $50,000, as
determined using the Black-Scholes option pricing model, and (ii) to the Outside Director who is serving as Chairman of the Board at the time of the annual meeting, if any, an Annual Option to purchase such number of shares of Common Stock
having a value, as of such date, that is equal to $15,000, as determined using the Black-Scholes option pricing model. An Annual Option shall vest in full after a period of 12 months and, in the event of a change in control of the Corporation, the
option will accelerate in full. 
 Annual Options shall (i) have an exercise price equal to the Fair Market Value (as
defined in the Plan) of the Corporation’s Common Stock on the date of grant, (ii) expire on the earlier of 10 years from the date of grant or 24 months following cessation of service on the Board and (iii) contain such other terms and
conditions as the Board shall determine. 
 The obligation to grant Annual Options under the Plan to an Outside Director shall,
if so determined by the Board, be reduced to the extent the Corporation is otherwise obligated to grant, or the Board otherwise grants or has granted, options to such Outside Director. 
 Reimbursement of Expenses 
 The Corporation shall reimburse each member of
the Board for reasonable travel and other out-of-pocket expenses incurred in connection with attending meetings of the Board and its committees.EX-10.1

 Exhibit 10.1 
 STOCK PURCHASE AGREEMENT 
 THIS STOCK PURCHASE AGREEMENT is made and
entered into as of March 7, 2013, by and between Union First Market Bankshares Corporation, a Virginia corporation (the “Company”), and Markel Corporation, a Virginia corporation (the “Seller”). 

WITNESSETH: 
 The Seller desires to sell, and the Company desires to purchase, 500,000 shares of common stock of the Company (the “Offered Shares”) for the consideration and on the terms set forth in this
Agreement. In view of Steven A. Markel’s position as a director of the Company and as Vice Chairman of the Seller, this transaction has been authorized and approved by a special committee of disinterested directors of the Company in accordance
with Section 13.1-691 of the Virginia Stock Corporation Act. 
 The parties, intending to be legally bound, agree as
follows: 
 1. Purchase and Sale of Shares. The Company hereby agrees to purchase from the Seller and the Seller hereby
agrees to sell to the Company, on the Closing Date (as defined below), the Offered Shares free and clear of all Encumbrances (as defined below) for the Purchase Price. The Purchase Price shall be Nine Million Five Hundred Thousand dollars
($9,500,000.00). 
 2. Closing; Delivery of and Payment for the Offered Shares. Subject to the terms
and conditions herein, the closing of the purchase and sale of the Offered Shares shall take place on March 7, 2013 (the “Closing Date”) at 2:00 p.m. Eastern Time at the offices of LeClairRyan, A Professional Corporation, Riverfront
Plaza, East Tower, 951 East Byrd Street, 8th Floor,
Richmond, Virginia 23221, or such later date as may be agreed to by the parties, subject to the provisions of Section 6. Immediately following confirmation of receipt of a wire transfer of the Purchase Price to the account designated on
Schedule 1 hereto, the Seller shall deliver the Offered Shares to the Company or its authorized agents. 
 3.
Representations and Warranties. 
 (a) The Seller represents and warrants to the Company that: 

 

	 	(i)	The Seller is a corporation duly incorporated, validly existing and in good standing under the laws of the Commonwealth of Virginia; 

 

	 	(ii)	 The execution and delivery of this Agreement have been duly and validly authorized, and all necessary action has

	 	
been taken to make this Agreement a legal, valid and binding obligation of the Seller, enforceable in accordance with its terms; and 

 

	 	(iii)	The Seller is not, and will not become, a party to any agreement, arrangement or understanding with any person that could result in the Company having any obligation or
liability for any brokerage fees, commissions or other similar fees or expenses relating to the transaction contemplated by this Agreement; 

  

	 	(iv)	The Seller has good, valid and marketable title to the Offered Shares, free and clear of any and all Encumbrances (“Encumbrance” shall mean any security
interest, pledge, lien, charge, voting agreement, proxy, mortgage, option, adverse claim of ownership or use, or any other encumbrance of any kind, character or description whatsoever); and 

 

	 	(v)	The Seller has the sole right to dispose or direct the disposition of the Offered Shares. 

(b) The Company represents and warrants to the Seller that: 

 

	 	(i)	The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the Commonwealth of Virginia; 

 

	 	(ii)	The execution and delivery of this Agreement have been duly and validly authorized, and all necessary action has been taken to make this Agreement a legal, valid and
binding obligation of the Company, enforceable in accordance with its terms; and 

  

	 	(iii)	The Purchase Price payable to the Seller shall be paid as set forth in this Agreement without any deductions or withholdings by any person for brokerage fees,
commissions, taxes or other similar fees or expenses relating to the transaction contemplated by this Agreement. 

4. Investigation. Each party has conducted its own investigation with respect to the Offered Shares, acknowledges that the other
party may be in possession of material, nonpublic information regarding the Company, and agrees that the other party has no obligation to disclose such information to such party. 

  
 2 

 5. Closing Conditions. 

(a) The obligation of the Company to purchase the Offered Shares on the Closing Date is subject to the satisfaction, on or prior to the
Closing Date, of the following conditions: 
  

	 	(i)	The representations and warranties made by the Seller in Section (3)(a) of this Agreement shall be true and correct in all material respects as of the Closing
Date. 

 (b) The obligation of the Seller to sell the Offered Shares on the Closing Date is subject to the
satisfaction, on or prior to the Closing Date, of the following condition: 
  

	 	(i)	The representations and warranties made by the Company in Section (3)(b) of this Agreement shall be true and correct in all material respects as of the Closing
Date. 

 6. Termination. The Company or the Seller may terminate this Agreement, by notice to the other, if
the Closing has not occurred by March 13, 2013 other than by reason of a breach of this Agreement by the party seeking to terminate. 
 7. Miscellaneous. 
 (a) This Agreement shall be governed by and construed
in accordance with the laws of the Commonwealth of Virginia. 
 (b) This Agreement shall be binding upon the respective
successors and assigns of the parties hereto. 
 (c) In the event that any provision of this Agreement is adjudicated invalid,
illegal or unenforceable, such adjudication shall not affect the validity, legality or enforceability of any other provision, and this Agreement shall be construed as though such invalid, illegal or unenforceable provision had never been contained
herein. 
 (d) The Seller and the Company agree that money damages are inadequate and that each will suffer irreparable harm
with respect to a failure to abide by any covenant made under the terms of this Agreement or any requirement under this Agreement relating to or affecting the sale of the Offered Shares, and that, accordingly, in addition to any money damages which
might be awarded with reasonable certainty, each shall be entitled to demand specific performance or to seek injunctive relief whether with regard to a breach or contemplated breach. All rights, remedies and benefits specified in this Agreement,
including, but not limited to the rights, remedies and benefits contained in this Section 7(d) are not exclusive of any rights, remedies or benefits which any party may otherwise have. 

  
 3 

 (e) This Agreement may be executed in multiple counterparts, each of which shall be deemed
an original, but all of which taken together shall constitute one and the same instrument. 
 (f) This Agreement constitutes the
entire agreement between the parties and no term or provision of this Agreement may be waived or modified unless in writing signed by the party against whom such waiver or modification is sought to be enforced. 

[Signatures on the following page] 

  
 4 

 WITNESS the following signatures: 

 

			
	UNION FIRST MARKET BANKSHARES CORPORATION
		
	By:	 	 /s/ G. William Beale

		 	G. William Beale
		 	Chief Executive Officer
	
	MARKEL CORPORATION
		
	By:	 	 /s/ Richard R. Whitt, III

		 	Richard R. Whitt, III
		 	President and Co-Chief Operating Officer

  
 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}]]